BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21885439)

  • 1. Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway.
    Hsu YL; Huang MS; Yang CJ; Hung JY; Wu LY; Kuo PL
    J Biol Chem; 2011 Oct; 286(43):37335-46. PubMed ID: 21885439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
    Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
    Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity.
    Jun JH; Yoon WJ; Seo SB; Woo KM; Kim GS; Ryoo HM; Baek JH
    J Biol Chem; 2010 Nov; 285(47):36410-9. PubMed ID: 20851880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
    Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
    Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression.
    Hsu YL; Huang MS; Cheng DE; Hung JY; Yang CJ; Chou SH; Kuo PL
    J Immunol; 2011 Aug; 187(4):1733-44. PubMed ID: 21742971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM Mineralization Protein-1 Enhances Bone Morphogenetic Protein-2-Mediated Osteogenesis Through Activation of ERK1/2 MAPK Pathway and Upregulation of Runx2 Transactivity.
    Pan H; Li X; Wang J; Zhang K; Yang H; Li Z; Zheng Z; Liu H
    J Bone Miner Res; 2015 Aug; 30(8):1523-35. PubMed ID: 25677945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation.
    Huang RL; Yuan Y; Tu J; Zou GM; Li Q
    Cell Death Dis; 2014 Apr; 5(4):e1187. PubMed ID: 24743742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
    Lu Z; Wang G; Dunstan CR; Zreiqat H
    Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways.
    Celil AB; Campbell PG
    J Biol Chem; 2005 Sep; 280(36):31353-9. PubMed ID: 16000303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor-induced BMP-2 expression is mediated by c-Met receptor, FAK, JNK, Runx2, and p300 pathways in human osteoblasts.
    Tsai SY; Huang YL; Yang WH; Tang CH
    Int Immunopharmacol; 2012 Jun; 13(2):156-62. PubMed ID: 22504529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells.
    Tandon M; Gokul K; Ali SA; Chen Z; Lian J; Stein GS; Pratap J
    Mol Cancer; 2012 Jun; 11():27. PubMed ID: 22537242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling Pathway.
    Dong M; Jiao G; Liu H; Wu W; Li S; Wang Q; Xu D; Li X; Liu H; Chen Y
    Biol Trace Elem Res; 2016 Oct; 173(2):306-15. PubMed ID: 27025722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.
    Ge C; Yang Q; Zhao G; Yu H; Kirkwood KL; Franceschi RT
    J Bone Miner Res; 2012 Mar; 27(3):538-51. PubMed ID: 22072425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway.
    Hisa I; Inoue Y; Hendy GN; Canaff L; Kitazawa R; Kitazawa S; Komori T; Sugimoto T; Seino S; Kaji H
    J Biol Chem; 2011 Mar; 286(11):9787-96. PubMed ID: 21239498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
    Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
    J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein-5, a key molecule that mediates differentiation in MC3T3E1 osteoblast cell line.
    Vijayan V; Gupta S; Gupta S
    Biofactors; 2017 Jul; 43(4):558-566. PubMed ID: 28497879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.
    Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R
    Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.